Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients

Table 1

The frequency of HeyL promoter methylation status in COVID-19 patients compared to that in the control group.

	COVID-19; patients; (%)	Control; (%)	Odd ratio (OR)	95% CI		value
Partial-methylated	22 (73.3)	9 (45)	3.3611	1.0162-11.117	1.986	0.047
Unmethylated	8 (26.6)	11 (55)

A standard normal deviate (-value) is calculated as ln(OR)/ynn{ln(OR)}. CI: confidence interval. value for comparing between the frequency of partial-methylated and unmethylated promoter of HeyL gene among COVID-19 patients and the control group. Statistically significant at .